Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 22, 2024
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
[ Mon, Jul 22nd 2024
] - WOPRAI
Mani Foroohar Initiated (BNTC) at Buy and Held Target at $13 on, Jul 22nd, 2024
Mani Foroohar of Leerink Partners, Initiated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $13 on, Jul 22nd, 2024.
Mani has made no other calls on BNTC in the last 4 months.
There are 2 other peers that have a rating on BNTC. Out of the 2 peers that are also analyzing BNTC, 0 agree with Mani's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mani
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Thursday, June 13th, 2024
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Increased Target to $16 on, Monday, April 22nd, 2024
